David Larsen
Stock Analyst at BTIG
(2.13)
# 2,937
Out of 5,133 analysts
93
Total ratings
38.67%
Success rate
-1.67%
Average return
Main Sectors:
Stocks Rated by David Larsen
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| MDLN Medline | Initiates: Buy | $50 | $42.72 | +17.04% | 1 | Jan 12, 2026 | |
| BTSG BrightSpring Health Services | Maintains: Buy | $41 → $50 | $39.01 | +28.17% | 4 | Dec 23, 2025 | |
| SLP Simulations Plus | Downgrades: Neutral | n/a | $18.91 | - | 4 | Dec 18, 2025 | |
| LFST LifeStance Health Group | Maintains: Buy | $9 → $10 | $7.46 | +34.05% | 2 | Dec 12, 2025 | |
| PIII P3 Health Partners | Suspends: Neutral | n/a | $2.95 | - | 3 | Dec 12, 2025 | |
| AGL agilon health | Suspends: Neutral | n/a | $0.99 | - | 2 | Dec 12, 2025 | |
| HQY HealthEquity | Reiterates: Buy | $130 | $84.56 | +53.74% | 5 | Dec 4, 2025 | |
| VEEV Veeva Systems | Reiterates: Buy | $340 | $233.21 | +45.79% | 4 | Nov 21, 2025 | |
| LFMD LifeMD | Maintains: Buy | $18 → $10 | $4.19 | +138.66% | 4 | Nov 18, 2025 | |
| EVH Evolent Health | Maintains: Buy | $20 → $16 | $4.15 | +285.54% | 7 | Nov 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $50 → $45 | $29.21 | +54.06% | 2 | Nov 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $85 | $32.34 | +162.83% | 2 | Nov 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $7 | $3.85 | +81.82% | 1 | Oct 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $10 → $15 | $10.65 | +40.85% | 4 | Sep 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Neutral | n/a | $2.46 | - | 4 | Sep 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $80 | $43.86 | +82.40% | 2 | Jun 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $28 | $28.42 | -1.48% | 4 | Mar 31, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $30 → $31 | $22.66 | +36.80% | 3 | Nov 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $290 → $260 | $240.86 | +7.95% | 2 | Nov 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $7 | $2.54 | +175.59% | 1 | Sep 17, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $11 → $7 | $0.90 | +680.03% | 4 | May 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $51.19 | - | 7 | Nov 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $35 | $23.44 | +49.35% | 1 | Apr 28, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $7.25 | - | 3 | Nov 22, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | n/a | $4.96 | - | 1 | Jan 7, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Market Perform | n/a | $202.52 | - | 6 | Nov 16, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Market Perform | $170 → $160 | $825.62 | -80.62% | 2 | May 29, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Outperform | n/a | $76.13 | - | 5 | Apr 4, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $90 → $85 | $80.36 | +5.77% | 3 | Feb 9, 2018 |
Medline
Jan 12, 2026
Initiates: Buy
Price Target: $50
Current: $42.72
Upside: +17.04%
BrightSpring Health Services
Dec 23, 2025
Maintains: Buy
Price Target: $41 → $50
Current: $39.01
Upside: +28.17%
Simulations Plus
Dec 18, 2025
Downgrades: Neutral
Price Target: n/a
Current: $18.91
Upside: -
LifeStance Health Group
Dec 12, 2025
Maintains: Buy
Price Target: $9 → $10
Current: $7.46
Upside: +34.05%
P3 Health Partners
Dec 12, 2025
Suspends: Neutral
Price Target: n/a
Current: $2.95
Upside: -
agilon health
Dec 12, 2025
Suspends: Neutral
Price Target: n/a
Current: $0.99
Upside: -
HealthEquity
Dec 4, 2025
Reiterates: Buy
Price Target: $130
Current: $84.56
Upside: +53.74%
Veeva Systems
Nov 21, 2025
Reiterates: Buy
Price Target: $340
Current: $233.21
Upside: +45.79%
LifeMD
Nov 18, 2025
Maintains: Buy
Price Target: $18 → $10
Current: $4.19
Upside: +138.66%
Evolent Health
Nov 7, 2025
Maintains: Buy
Price Target: $20 → $16
Current: $4.15
Upside: +285.54%
Nov 7, 2025
Maintains: Buy
Price Target: $50 → $45
Current: $29.21
Upside: +54.06%
Nov 4, 2025
Reiterates: Buy
Price Target: $85
Current: $32.34
Upside: +162.83%
Oct 21, 2025
Reiterates: Buy
Price Target: $7
Current: $3.85
Upside: +81.82%
Sep 18, 2025
Maintains: Buy
Price Target: $10 → $15
Current: $10.65
Upside: +40.85%
Sep 5, 2025
Reiterates: Neutral
Price Target: n/a
Current: $2.46
Upside: -
Jun 2, 2025
Upgrades: Buy
Price Target: $80
Current: $43.86
Upside: +82.40%
Mar 31, 2025
Upgrades: Buy
Price Target: $28
Current: $28.42
Upside: -1.48%
Nov 11, 2024
Maintains: Buy
Price Target: $30 → $31
Current: $22.66
Upside: +36.80%
Nov 1, 2024
Maintains: Buy
Price Target: $290 → $260
Current: $240.86
Upside: +7.95%
Sep 17, 2024
Initiates: Buy
Price Target: $7
Current: $2.54
Upside: +175.59%
May 9, 2024
Maintains: Buy
Price Target: $11 → $7
Current: $0.90
Upside: +680.03%
Nov 3, 2023
Downgrades: Neutral
Price Target: n/a
Current: $51.19
Upside: -
Apr 28, 2022
Initiates: Buy
Price Target: $35
Current: $23.44
Upside: +49.35%
Nov 22, 2021
Downgrades: Neutral
Price Target: n/a
Current: $7.25
Upside: -
Jan 7, 2021
Initiates: Neutral
Price Target: n/a
Current: $4.96
Upside: -
Nov 16, 2018
Downgrades: Market Perform
Price Target: n/a
Current: $202.52
Upside: -
May 29, 2018
Maintains: Market Perform
Price Target: $170 → $160
Current: $825.62
Upside: -80.62%
Apr 4, 2018
Upgrades: Outperform
Price Target: n/a
Current: $76.13
Upside: -
Feb 9, 2018
Maintains: Outperform
Price Target: $90 → $85
Current: $80.36
Upside: +5.77%